Translational development of active immunotherapy for hematologic malignancies

Seminars in Oncology

Volumn 30, Issue 3 SUPPL. 8, 2003, Pages 17-22

  Kwak, Larry W ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA DEFENSIN; CANCER VACCINE; CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IDIOTYPE ANTIGEN; KEYHOLE LIMPET HEMOCYANIN; MONOCYTE CHEMOTACTIC PROTEIN 3; TOLL LIKE RECEPTOR 4; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ANTIGEN PRESENTING CELL; CANCER CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CANCER SURVIVAL; CELLULAR IMMUNITY; CLINICAL TRIAL; DENDRITIC CELL; FOLLICULAR LYMPHOMA; HEMATOLOGIC MALIGNANCY; HUMAN; HUMORAL IMMUNITY; NONHUMAN; PRIORITY JOURNAL; REVIEW; RNA TRANSLATION; T LYMPHOCYTE; VACCINATION;

EID: 0041802772     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0093-7754(03)00232-X     Document Type: Review

References (9)

1. Kwak LW, Campbell M, Levy R: Idiotype vaccination post-bone marrow transplantation for B cell lymphoma: Initial studies in a murine model. Cancer Detect Prev 15:323-325, 1991
2. Kwak LW, Campbell MJ, Czerwinski DK, et al: Induction of immune responses in patients with B cell lymphoma against the surface-immunoglobulin idiotype expressed by their tumours. N Engl J Med 327:1209-1215, 1992
3. Kwak LW, Young HA, Pennington RW, et al: Vaccination with syngeneic, lymphoma-derived immunoglobulin idiotype combined with granulocyte/macrophage colony-stimulating factor primes mice for a protective T cell response. Proc Natl Acad Sci U S A 93:10972-10977, 1996
4. Bendandi M, Gocke CD, Kobrin CB, et al: Complete molecular remissions induced by patient-specific vaccination plus granulocyte-monocyte colony-stimulating factor against lymphoma. Nature Med 5:1171-1177, 1999
5. Hsu FJ, Benike C, Fagnoni F, et al: Vaccination of patients with B cell lymphoma using autologous antigen-pulsed dendritic cells. Nature Med 2:52-58, 1996
6. Hsu FJ, Caspar CB, Czerwinski D, et al: Tumor-specific idiotype vaccines in the treatment of patients with B cell lymphoma: Long-term results of a clinical trial. Blood 9:3129-3135, 1997
7. Timmerman JM, Czerwinski DK, Davis TA, et al: Idiotype-pulsed dendritic cell vaccination for B cell lymphoma: Clinical and immune responses in 35 patients. Blood 99:1517-1526, 2002
8. Biragyn A, Tani K, Grimm MC, et al: Genetic fusion of chemokines to a self tumor antigen induces protective, T-cell dependent antitumor immunity. Nature Biotech 17:253-258, 1999
9. Biragyn A, Ruffini PA, Leifer CA, et al: Toll-like receptor 4-dependent activation of dendritic cells by beta-defensin 2. Science 298:1025-1029, 2002